Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01627-16
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Safety, Tolerability, and Pharmacokinetics of the Novel Anti-Influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings

Clinical Drug Investigation
MedicinePharmacology
2018English

Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986142, a Novel Reversible BTK Inhibitor, in Healthy Participants

European Journal of Clinical Pharmacology
MedicinePharmacology
2017English

Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy Individuals

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E3024, a Novel and Selective Dipeptidyl Peptidase-Iv Inhibitor, in Healthy Japanese Male Subjects: Rash Development in Men and Its Possible Mechanism

Pharmacology & Pharmacy
2013English

Single-Dose Pharmacokinetics of Ceftriaxone in Healthy Chinese Adults.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1985English

Pharmacokinetics of Cefmetazole Administered Intramuscularly and Intravenously to Healthy Adults.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1985English

Safety, Tolerability and Pharmacokinetics of Higher-Dose Mizoribine in Healthy Male Volunteers

British Journal of Clinical Pharmacology
Pharmacology
2007English

Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy